Virtus ETF Advisers’s Dr. Reddy's Laboratories RDY Stock Holding History

Virtus ETF Advisers’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55M	Hold	107,110	–	–	0.6%	26
2026 Q1	$1.48M	Sell	107,110 -9,835	-8%	-$137K	0.69%	23
2025 Q4	$1.64M	Hold	116,945	–	–	0.78%	18
2025 Q3	$1.63M	Sell	116,945 -2,000	-2%	-$28.8K	0.9%	20
2025 Q2	$1.79M	Hold	118,945	–	–	1.09%	14
2025 Q1	$1.57M	Buy	+118,945	New	+$1.64M	1.02%	14
2020 Q1	–	Sell	-50	Closed	–	–	469
2019 Q4	$0	Sell	50 -120	-71%	-$948	﹤0.01%	502
2019 Q3	$1K	Sell	170 -65	-28%	-$483	﹤0.01%	435
2019 Q2	$2K	Buy	+235	New	+$1.85K	﹤0.01%	433

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Virtus ETF Advisers's RDY Position: Q2 2026 in Review

Virtus ETF Advisers held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 107,110 shares worth $1.55M. The position accounts for 0.6% of the portfolio, ranked #26.

Virtus ETF Advisers first reported a position in RDY in Q2 2019 and has held it in 9 quarters since. The position peaked at $1.79M in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Virtus ETF Advisers held 107,110 shares of Dr. Reddy's Laboratories worth $1.55M as of Q2 2026.
Virtus ETF Advisers left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up 0.6% of Virtus ETF Advisers's portfolio in Q2 2026, its #26 holding.
Virtus ETF Advisers first reported a position in Dr. Reddy's Laboratories in Q2 2019 and has held it in 9 quarters since.
Virtus ETF Advisers's Dr. Reddy's Laboratories position peaked at $1.79M in Q2 2025.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.